“Thymic carcinoma is a rare cancer with poor prognosis after recurrence, and there is a need for new treatment options. We are working to obtain approval so that Tecentriq that demonstrated favourable ...

ILC accounts for 10–15% of breast cancers and often goes undetected. Learn about its characteristics, treatments, and future ...

A proteomics-driven 24-protein classifier improves the differentiation of thyroid adenoma and carcinoma, retrospectively and ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Credit: NIAID In the early 1960s, Professor Jaques Miller discovered the essential role of the thymus in our immune systems while working as a PhD student at The Institute of Cancer Research in London ...

as well as continuing refinements in molecular pathology and imaging. The increased personalisation of cancer therapy, introduction of multidisciplinary treatment approaches, and widespread adoption ...

Researchers found that the Wnt5a protein, secreted by inflammatory fibroblasts within cancerous tumors, inhibits angiogenesis and consequently promotes hypoxia within tumors. Hypoxic conditions help ...

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

Complete Pathologic Response reported in 2 patients in the Third Cohort with cutaneous squamous cell carcinoma, complementing results in prior cohort Marlborough, Massachusetts--(Newsfile Corp ...

The Centre for Molecular Pathology is a collaborative initiative between The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, aiming to identify the molecular mechanisms that ...